Evidence map›Paper›PMID 34262113›Full record

Trial reportScientific reports2021

Prospective, comparative clinical pilot study of cold atmospheric plasma device in the treatment of atopic dermatitis.

Young Jae Kim, Dong Jun Lim, Mi Young Lee, Woo Jin Lee, Sung Eun Chang, Chong Hyun Won

Open access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. European S2k Guideline on Chronic PruritusActa dermato-venereologica · 2025
    Guideline
  2. Penetration depth of cold atmospheric plasma into biological tissue: a review.Frontiers in bioengineering and biotechnology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Intracellular Habitation ofBiomedicines · 2022
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Young Jae KimDepartment of Dermatology, Asan Medical Center, Ulsan University College of Medicine, 88, OLYMPIC-RO 43-GIL Songpa-gu, Seoul, 05505, South Korea.
Dong Jun LimDepartment of Dermatology, Asan Medical Center, Ulsan University College of Medicine, 88, OLYMPIC-RO 43-GIL Songpa-gu, Seoul, 05505, South Korea.
Mi Young LeeDepartment of Dermatology, Asan Medical Center, Ulsan University College of Medicine, 88, OLYMPIC-RO 43-GIL Songpa-gu, Seoul, 05505, South Korea.
Woo Jin LeeDepartment of Dermatology, Asan Medical Center, Ulsan University College of Medicine, 88, OLYMPIC-RO 43-GIL Songpa-gu, Seoul, 05505, South Korea.
Sung Eun ChangDepartment of Dermatology, Asan Medical Center, Ulsan University College of Medicine, 88, OLYMPIC-RO 43-GIL Songpa-gu, Seoul, 05505, South Korea.
Chong Hyun WonDepartment of Dermatology, Asan Medical Center, Ulsan University College of Medicine, 88, OLYMPIC-RO 43-GIL Songpa-gu, Seoul, 05505, South Korea. drwon@amc.seoul.kr.
Asan Medical Center · KRUniversity of Ulsan · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold atmospheric plasma generates free radicals through the ionization of air at room temperature. Its effect and safety profile as a treatment modality for atopic dermatitis lesions have not been evaluated prospectively enough. We aimed to investigate the effect and safety of cold atmospheric plasma in patients with atopic dermatitis with a prospective pilot study. Cold atmospheric plasma treatment or sham control treatment were applied respectively in randomly assigned and symmetric skin lesions. Three treatment sessions were performed at weeks 0, 1, and 2. Clinical severity indices were assessed at weeks 0, 1, 2, and 4 after treatment. Additionally, the microbial characteristics of the lesions before and after treatments were analyzed. We included 22 patients with mild to moderate atopic dermatitis presented with symmetric lesions. We found that cold atmospheric plasma can alleviate the clinical severity of atopic dermatitis. Modified atopic dermatitis antecubital severity and eczema area and severity index score were significantly decreased in the treated group. Furthermore, scoring of atopic dermatitis score and pruritic visual analog scales significantly improved. Microbiome analysis revealed significantly reduced proportion of Staphylococcus aureus in the treated group. Cold atmospheric plasma can significantly improve mild and moderate atopic dermatitis without safety issues.

Indexed as

Dermatitis, AtopicPlasma GasesAdolescentAdultFemaleHumansMaleMicrobiotaMiddle AgedPilot ProjectsProspective StudiesSeverity of Illness IndexStaphylococcus aureusTreatment OutcomeYoung AdultPlasma Gases

Identifiers

PMID34262113
PMCPMC8280139
OpenAlexW3157873911

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.